- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Cardinal Health Inc. (CAH)
by latest | most commented
-
When Timing Meets Opportunity: Which Dividend Achievers Are at a 52-Week Low?
-
9 Stocks Giving Dividend Raises in Q209
-
Analysis: Cardinal Health Is Undervalued
-
Short Sellers Diving into Healthcare
-
81 Dividend Growers to Consider
-
Dividend Increases and Buybacks: WMT, CAH, and UHT
-
3 Stocks That Boost Equity Value by Boosting Dividends
-
20 'Bathwater Babies' and 20 'Dogs with Fleas' for the Week
-
Wall Street Breakfast: Must-Know News
-
Maverick Capital's 13F Filing for Q408
-
AmerisourceBergen Corp: A Healthy Dosage for Your Portfolio
-
Cardinal Health: A Grainger-Like Investment
-
Wall Street Breakfast: Must-Know News
-
Are All Healthcare Stocks Truly Recession-Proof?
-
Companies in Shape, and Looking Good...
-
Hedge Fund Portfolio Tracking: Renaissance Technologies (Jim Simons), Q3 2008
-
Cardinal Health, Intuitive Surgical Injured by the Economy
-
Ten Native Stocks of Ohio
-
Investing in Stocks: Emotional vs. Financial Costs
-
Hedge Fund Tracking: Lee Ainslie's Maverick Capital, Q3 2008
-
When Funds Clear Out: A Fiscal Year-End Stock Screen
-
Wall Street Breakfast: Must-Know News
-
Recessionary Equity Strategies: The Price Is Right
-
Earnings Preview: Cardinal Health
-
Wall Street Breakfast: Must-Know News
-
Earnings Preview: Cardinal Health
-
Wall Street Breakfast: Must-Know News
-
Cardinal Health Sinks on Disappointing Outlook
-
Cardinal Health Comes Back to Life - Barron's
-
Cardinal Health Beats On EPS, Misses On Revenue
-
Cardinal Health Forecasts '07 EPS at Top End, Reiterates '08 Guidance
-
Biotech Buyout Frenzy Continues
-
Cardinal Health: Litigation, Sale and Acquisition Leave 2007 EPS Unchanged
-
Cardinal Health to Buy VIASYS Healthcare for $1.5B, 35% Premium
-
New Buy Ideas: 15 Stocks I Expect To Breakout
-
Cardinal Health to Sell Its Drugmaking Unit for a Surprising $3.3 Billion
-
Biotech Stocks Day-In-Review: Amgen Disappoints After The Bell
-
Cardinal Health Selling Packaging Unit To Concentrate on Core Distribution Biz
-
Streaking Stocks: Goldman Sachs Up 12 Days in a Row
-
Cardinal Health: Waiting for an Entry Point
-
AmerisourceBergen's Return to Health